Company Filing History:
Years Active: 2017-2022
Title: Innovations of Li-Chang Chen in Cancer Treatment
Introduction
Li-Chang Chen is a notable inventor based in San Diego, CA, who has made significant contributions to the field of cancer treatment. He holds 2 patents that focus on advancements in arginine deiminase proteins, which are crucial for treating arginine-dependent diseases.
Latest Patents
Li-Chang Chen's latest patents include innovations related to arginine deiminase (ADI) proteins. His inventions focus on ADI proteins that exhibit reduced cross-reactivity with anti-ADI-PEG 20 antibodies compared to ADI-PEG 20. These proteins maintain functional characteristics that are comparable to or better than ADI-PEG 20. The compositions comprising these ADI proteins are aimed at treating arginine-dependent diseases, including various forms of cancer.
Career Highlights
Throughout his career, Li-Chang Chen has worked with prominent companies such as Polaris Group and Tdw Group. His work in these organizations has contributed to the development of innovative treatments in the medical field.
Collaborations
Li-Chang Chen has collaborated with notable professionals in his field, including Richard E Showalter and Robert Almassy. These collaborations have further enhanced his research and development efforts.
Conclusion
Li-Chang Chen's contributions to cancer treatment through his patented innovations in arginine deiminase proteins highlight his role as a significant inventor in the medical research community. His work continues to pave the way for advancements in treating arginine-dependent diseases.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.